4.5 Article

Pathologic correlates of supranuclear gaze palsy with parkinsonism

Journal

PARKINSONISM & RELATED DISORDERS
Volume 38, Issue -, Pages 68-71

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2017.02.027

Keywords

Supranuclear gaze palsy; Progressive supranuclear palsy; Parkinsonism; Parkinson disease

Funding

  1. NIH grants from the National Institute of Neurological Disorders and Stroke [NS075321, NS41509, NS058714, NS48924]
  2. National Institute of Environmental Health Sciences [K24ES17765]
  3. Greater St. Louis Chapter of the American Parkinson Disease Association (APDA)
  4. APDA Advanced Research Center for Parkinson Disease at Washington University in St Louis
  5. Barnes Jewish Hospital Foundation (Elliot Stein Family Fund)
  6. Barnes Jewish Hospital Foundation (Oertli Fund)
  7. Barnes Jewish Hospital Foundation (Parkinson Disease Research Fund)

Ask authors/readers for more resources

Introduction: Supranuclear gaze palsy (SGP) is a classic clinical feature of progressive supranuclear palsy (PSP) but is not specific for this diagnosis and has been reported to occur in several other neurodegenerative parkinsonian conditions. Our objective was to evaluate the association between SGP and autopsy-proven diagnoses in a large population of patients with parkinsonism referred to a tertiary movement disorders clinic. Methods: We reviewed clinical and autopsy data maintained in an electronic medical record from all patients seen in the Movement Disorders Clinic at Washington University, St. Louis between 1996 and 2015. All patients with parkinsonism from this population who had subsequent autopsy confirmation of diagnosis underwent further analysis. Results: 221 unique parkinsonian patients had autopsy-proven diagnoses, 27 of whom had SGP documented at some point during their illness. Major diagnoses associated with SGP were: PSP (9 patients), Parkinson disease (PD) (10 patients), multiple system atrophy (2 patients), corticobasal degeneration (2 patients), Creutzfeld-Jakob disease (1 patient) and Huntington disease (1 patient). In none of the diagnostic groups was the age of onset or disease duration significantly different between cases with SGP and those without SGP. In the PD patients, the UPDRS motor score differed significantly between groups (p = 0.01) with the PD/SGP patients having greater motor deficit than those without SGP. Conclusion: Although a common feature of PSP, SGP is not diagnostic for this condition and can be associated with other neurodegenerative causes of parkinsonism including PD. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available